MedTech Global Insights
Episodes
US FDA's Health App Crackdown: The Compliance Trap | Pure Global
26 Jan 2026
Contributed by Lukas
This week, we dissect the FDA's newly released guidance on General Wellness and Clinical Decision Support software. This isn't just a minor update; it...
Pure Global: USA's New AI Device Rules - A Speed Trap?
25 Jan 2026
Contributed by Lukas
This week, we dissect the FDA's bombshell draft guidance on AI/ML-enabled medical devices. The new framework for Predetermined Change Control Plans (P...
USA's Code Red Compliance: Pure Global on Device Cybersecurity
24 Jan 2026
Contributed by Lukas
The U.S. FDA has just escalated cybersecurity from a guideline to a mandatory gateway for market access. This episode of MedTech Global Insights unpac...
Pure Global: US MedTech's Urgent Cyber Mandate
23 Jan 2026
Contributed by Lukas
This week, we dissect the FDA's aggressive new stance on medical device cybersecurity, a shift causing major disruptions for manufacturers. What was o...
UK AI Diagnostics: Pure Global on MHRA's Risky New Pathway.
22 Jan 2026
Contributed by Lukas
This week on MedTech Global Insights, we dissect the UK MHRA's groundbreaking new accelerated approval pathway for AI-powered medical devices. This po...
EU's MDR Relief & Notified Body Rift: A Pure Global Brief
21 Jan 2026
Contributed by Lukas
The European Union's notoriously complex MDR and IVDR regulations have been a major challenge for the MedTech industry. Last week, the European Commis...
Pure Global: Europe's MedTech & The Post-Market Surprise
20 Jan 2026
Contributed by Lukas
Many MedTech companies breathe a sigh of relief after achieving their European CE mark, believing the hardest part is over. But a recent guidance docu...
USA LDT Crackdown: Pure Global on the New FDA Reality
19 Jan 2026
Contributed by Lukas
The FDA has finalized its groundbreaking rule, ending its long-standing enforcement discretion for Laboratory Developed Tests (LDTs). This episode unp...
Pure Global: SF MedTech's Post-JPM Deal Shockwaves
18 Jan 2026
Contributed by Lukas
This week, we dissect the massive $3.7 billion acquisition of Axonics by Boston Scientific. This deal, announced during the landmark J.P. Morgan Healt...
Pure Global: US Digital Health's TEMPO Pivot - Opportunity or Trap?
17 Jan 2026
Contributed by Lukas
The U.S. FDA just launched the TEMPO pilot program, a groundbreaking "regulatory-light" pathway for digital health devices. This episode of MedTech Gl...
USA's Digital Health TEMPO Trap: A Pure Global Critical Update
16 Jan 2026
Contributed by Lukas
In this episode of MedTech Global Insights, we dissect two monumental shifts in the U.S. regulatory landscape happening right now. The FDA is rolling ...
US Digital Health: Pure Global on the FDA's Deregulation Gamble
15 Jan 2026
Contributed by Lukas
Last week, the US FDA announced a major shift in policy, easing regulations for low-risk digital health products and wearables. This move, revealed at...
US/EU AI MedTech Split: Pure Global on Hidden Hurdles
14 Jan 2026
Contributed by Lukas
The promise of AI in medical devices is immense, but new guidance from US and European authorities reveals a widening gap in regulatory expectations. ...
U.S. MedTech SBOM Crisis: Pure Global's Post-Market Playbook
13 Jan 2026
Contributed by Lukas
In the first week of January 2026, the FDA activated a new, mandatory cybersecurity rule, fundamentally changing the requirements for U.S. market acce...
Pure Global: USA's Wearable Tech Greenlight & The Fine Line
12 Jan 2026
Contributed by Lukas
In this episode, we dissect the U.S. FDA's landmark decision from the first week of January 2026 to ease regulations on general wellness and digital h...
Pure Global: US MedTech & The Real Reason for FDA's QMS Crackdown
11 Jan 2026
Contributed by Lukas
This week, we dissect a critical trend impacting the US MedTech landscape: the sustained surge in FDA warning letters. This isn't a random enforcement...
Pure Global: The US FDA's Hidden AI MedTech Compliance Trap
10 Jan 2026
Contributed by Lukas
This week, we dissect a critical, under-the-radar policy shift from the US FDA concerning AI and machine learning medical devices. Regulators are crac...
USA MedTech AI: Pure Global on the FDA's Hidden PCCP Challenge
09 Jan 2026
Contributed by Lukas
This week, MedTech Global Insights dives into the US FDA's groundbreaking new final guidance on Predetermined Change Control Plans (PCCPs) for AI-enab...
USA AI Oncology: Beyond FDA De Novo - Pure Global Insights
08 Jan 2026
Contributed by Lukas
In this episode, we dissect the recent FDA De Novo approval of a revolutionary AI diagnostic tool for oncology. While the industry celebrates this mil...
USA's LDT Shift: Pure Global on the IVD Compliance Collision
07 Jan 2026
Contributed by Lukas
This week, MedTech Global Insights dives into the FDA's game-changing final rule to regulate Laboratory Developed Tests (LDTs) as medical devices. We ...
USA's AI SaMD Gatekeepers: Pure Global on the FDA's New Rules.
06 Jan 2026
Contributed by Lukas
The FDA just dropped a bombshell on the AI medical device world. On January 2nd, they unveiled the 'AI-Driven SaMD Pre-Certification Excellence Progra...
U.S. MedTech: Pure Global on FDA's New Real-World Data Rules
05 Jan 2026
Contributed by Lukas
In the final days of 2025, the U.S. FDA unveiled a pivotal shift in policy, now allowing broader use of Real-World Data (RWD) in medical device submis...
USA Connected Devices: The FDA's Cyber Wall | Pure Global
04 Jan 2026
Contributed by Lukas
In the final days of 2025, the medical device world felt the full force of the U.S. FDA's new cybersecurity mandate. With the 'Refuse to Accept' polic...
EU's AI MedTech Ambush: Pure Global on the New RWE Mandate
03 Jan 2026
Contributed by Lukas
In the final days of 2025, EU regulators issued a surprise mandate that reshapes the landscape for AI-driven medical devices. A new guidance requires ...
USA's RWD Shift: Pure Global on The New Evidence Backdoor
02 Jan 2026
Contributed by Lukas
In the final days of 2025, the US FDA made a pivotal change to how it evaluates medical devices, opening the door for Real-World Data (RWD) to take ce...
São Paulo's SaMD Gambit: Pure Global's Insider Guide
22 Dec 2025
Contributed by Lukas
Brazil has just opened a regulatory fast-track for AI medical devices, promising market approval in just 90 days. This is a massive opportunity for Me...
Pure Global: Brazil's AI MedTech Rush & Its Hidden Hurdles
21 Dec 2025
Contributed by Lukas
Brazil's health authority, ANVISA, recently announced an exciting fast-track approval pathway for AI and machine learning medical software. This move ...
Pure Global: Brussels' IVDR Delay, Escaping the Complacency Trap.
20 Dec 2025
Contributed by Lukas
Last week, the European Commission extended the challenging IVDR transition deadlines, giving diagnostic manufacturers more time. While this seems lik...
Europe's EUDAMED Deadline: The Final Countdown | A Pure Global Brief
19 Dec 2025
Contributed by Lukas
The European Commission has ended years of uncertainty by announcing a mandatory deadline for EUDAMED. As of May 28, 2026, medical device and IVD comp...
UK MedTech: Pure Global on GSK's Post-Brexit Regulatory Gateway
18 Dec 2025
Contributed by Lukas
This week, we unpack the major implications of the UK MHRA's landmark approval of GSK's new twice-yearly asthma treatment. This is more than a product...
Boston's AI Challenge: FDA's New Rules | A Pure Global Takedown
17 Dec 2025
Contributed by Lukas
Last week, the FDA unveiled a game-changing fast-track for AI diagnostics, but a hidden challenge is already causing chaos for unprepared companies. W...
Pure Global: USA MedTech's Risky QMS Shift Beyond ISO 13485
16 Dec 2025
Contributed by Lukas
The US FDA is making its biggest change to quality system regulations in a generation, harmonizing with the global ISO 13485 standard. This shift, man...
Pure Global: Brussels' AI Medical Device Compliance Trap
15 Dec 2025
Contributed by Lukas
The promise of AI in MedTech is undeniable, but a major regulatory storm is brewing in the European Union. A new, complex dual-compliance framework no...
Pure Global: US AI MedTech & The FDA's Regulatory Chaos
14 Dec 2025
Contributed by Lukas
The explosion of AI in MedTech is met with a tangled web of new global regulations. This week, we dissect the latest guidance from the IMDRF and explo...
US DHT Trials: FDA's Hidden Rules | A Pure Global Brief
13 Dec 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we dissect the FDA's newly finalized guidance on using Digital Health Technologies (DHTs) for remote data ...
Europe's New Cyber Rules: Pure Global on MedTech's Security Hurdles
12 Dec 2025
Contributed by Lukas
The European Union has rolled out tough new cybersecurity regulations for medical devices, forcing manufacturers to rethink their entire approach to p...
Brussels' MedTech Labyrinth: Pure Global on the WEEE-MDR Conflict
11 Dec 2025
Contributed by Lukas
This week, we dive into a major regulatory challenge brewing in the European Union. MedTech Europe has officially called on the European Commission to...
Pure Global: US AI Health-Tech and The Denial Algorithm
10 Dec 2025
Contributed by Lukas
The first week of December saw Artificial Intelligence take center stage in MedTech, but not always for the right reasons. While new systems promise t...
USA Digital Health: Navigating FDA's New Cybersecurity Chaos with Pure Global
09 Dec 2025
Contributed by Lukas
Last week, the US FDA's new digital health pilot program sent ripples through the MedTech industry. This is more than a simple regulatory update; it's...
Brazil's MedTech Maze: Pure Global's AI Escape from High Fees
08 Dec 2025
Contributed by Lukas
Traditional MedTech global expansion is broken, defined by premium consulting fees, opaque processes, and frustrating delays. This episode of MedTech ...
Germany to FDA: Pure Global's AI Crushes Doc Bottlenecks
07 Dec 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we tackle the silent killer of speed-to-market: regulatory documentation bottlenecks. As companies expand ...
Pure Global: Brazil's MedTech AI & Decoding Regulatory Chaos
06 Dec 2025
Contributed by Lukas
In the fast-paced world of MedTech, falling behind on regulatory changes isn't just a risk; it's a guarantee of costly delays and missed opportunities...
Pure Global: Brazil MedTech AI - Unlocking 75% Faster Entry
05 Dec 2025
Contributed by Lukas
Are you ready to accelerate your MedTech or IVD product's global launch by 75%? In this episode of MedTech Global Insights, we explore how Pure Global...
EU MedTech's Unfair Advantage: Pure Global's Zero-Cost AI Secret
04 Dec 2025
Contributed by Lukas
In an industry where regulatory costs and complexities can stifle innovation, Pure Global's AI platform emerges as a game-changer. This episode of Med...
Cracking the Code of Global MedTech Expansion: How Pure Global Navigates Complex Markets Like China
03 Dec 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the number one hurdle for ambitious medical device and IVD companies: navigating the fragmented...
Unlocking MedTech Success in China: Why a Tech-Forward Partner Like Pure Global is Your Key to Streamlining Global Market Access.
02 Dec 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the paradigm shift in global market access strategy. We move beyond the traditional, fragmented...
Unlocking APAC MedTech Markets: How Pure Global Delivers Faster Regulatory Answers with AI and a Global Database.
01 Dec 2025
Contributed by Lukas
Navigating the complex, ever-changing web of global MedTech regulations is a primary barrier to market entry. The traditional, manual approach is noto...
From Chaos to Clarity: Navigating MedTech Regulations in China with Pure Global's Actionable Checklists.
30 Nov 2025
Contributed by Lukas
The global MedTech regulatory landscape is a maze of constantly changing rules and fragmented information. Relying on static guides or old webinars le...
Unlocking Global MedTech Markets: Pure Global’s End-to-End Strategy for Launching in Brazil and Beyond
29 Nov 2025
Contributed by Lukas
Navigating the complex world of global MedTech regulations can be a major challenge. Many companies find themselves juggling multiple local consultant...
Global MedTech Delays: How Pure Global’s 24-Hour Workflow Slashed Market Entry Time in Brazil
28 Nov 2025
Contributed by Lukas
In the race for global market access, the biggest hurdle isn't always the regulations themselves, but the 24-hour clock. When your teams are spread ac...
Cracking the Code: Pure Global's Expert Guide to China's NMPA Approval and MedTech Market Success
27 Nov 2025
Contributed by Lukas
This episode of MedTech Global Insights dives deep into the strategic imperatives for entering China's complex medical device market. We demystify the...
The Hidden Risk in the United States MedTech Market: Mastering Annual FDA Renewals with Pure Global
26 Nov 2025
Contributed by Lukas
Entering the US MedTech market is a major achievement, but maintaining that access requires navigating critical annual compliance tasks. This episode ...
Pure Global's Guide to U.S. Market Entry: Mastering the FDA's US Agent and Official Correspondent Roles for Non-US Manufacturers
25 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we tackle a critical and often misunderstood requirement for non-US medical device manufacturers entering ...
Beyond the CE Mark: Pure Global's Guide to EUDAMED Data Literacy and Dossier Expertise for the EU Market
24 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the critical challenges and strategic solutions surrounding the EU's EUDAMED database. We move ...
Unlocking the EU Market: Why Pure Global Advocates for an Authorized Representative with Physical Presence in Germany for MDR/IVDR Success.
23 Nov 2025
Contributed by Lukas
This episode of MedTech Global Insights delves into the critical role of the EU Authorized Representative (AR) under the stringent MDR and IVDR. We ex...
Navigating the Global Maze of Telemedicine & RPM: How Pure Global Unlocks Market Access for MedTech Innovators
22 Nov 2025
Contributed by Lukas
The telemedicine and remote patient monitoring (RPM) revolution is here, promising a new era of accessible and personalized healthcare. But for innova...
Beyond the Scan: How Pure Global Navigates the AI and Photon-Counting Revolution in CT Technology for Global Market Access
21 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we delve into the technological revolution transforming Computed Tomography (CT) scanners. We explore the ...
From Local Success to Global Leader: Pure Global's Playbook for Orthopedic Implant Market Access
20 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we delve into the complex world of orthopedic joint replacement implants. While an aging global population...
Unlocking Global Markets for Wearable Cardiac Monitors: A Pure Global MedTech Insight on Navigating FDA, CE Mark, and Beyond
19 Nov 2025
Contributed by Lukas
This episode of MedTech Global Insights dives into the booming market of wearable cardiac monitoring devices. We explore the massive opportunity for i...
Unlocking Global MRI Markets with AI and Strategic Regulation: A Pure Global Deep Dive
18 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the intricate and high-stakes process of bringing advanced Magnetic Resonance Imaging (MRI) equ...
Navigating the Future of Surgery: Pure Global's Guide to Global Market Access for Surgical Robotics and Navigation Systems
17 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we venture into the operating room of the future, exploring the cutting-edge advancements in surgical robo...
Beyond FDA Approval: Pure Global's Playbook for Navigating the Global Regulatory Maze with Your Continuous Glucose Monitoring (CGM) Device
16 Nov 2025
Contributed by Lukas
The global market for Continuous Glucose Monitoring (CGM) devices is booming, offering incredible opportunities for MedTech innovators. However, the p...
The Global DTx Revolution: Cracking the Code on Digital Therapeutics Regulations with Pure Global
15 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the booming field of Digital Therapeutics (DTx). We uncover what sets these evidence-based soft...
Mastering the Maze: A Pure Global Guide to Global Market Access for Cardiovascular Drug-Eluting Stents
14 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the dynamic and challenging world of cardiovascular drug-eluting stents (DES). We uncover the t...
The Global IVD Maze: A Pure Global Deep Dive into Market Access Strategy, IVDR Hurdles, and Tech-Driven Solutions
13 Nov 2025
Contributed by Lukas
This episode of MedTech Global Insights explores the immense opportunities and hidden complexities of taking an In-Vitro Diagnostic (IVD) device to th...
Pure Global Presents: Mastering the MDSAP Audit (AU P0002.008) - Key Criteria for Global MedTech Market Access
12 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we dissect the audit criteria of the Medical Device Single Audit Program (MDSAP), focusing on the specific...
From Device Malfunction to FDA Report: A Pure Global Guide to Mastering 21 CFR Part 803 Compliance
11 Nov 2025
Contributed by Lukas
Navigating the FDA's Medical Device Reporting (MDR) regulation, 21 CFR Part 803, is a high-stakes requirement for any MedTech company in the US market...
Mastering Medical Device Safety: Pure Global's Expert Guide to the ISO 10993-1 Biological Evaluation Requirements
10 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we dissect the essential requirements of ISO 10993-1 for the biological evaluation of medical devices. We ...
Pure Global's Ultimate Guide to Structuring Your EU IVDR 2017/746 Technical File for Market Success
09 Nov 2025
Contributed by Lukas
This episode of MedTech Global Insights offers a deep dive into one of the most challenging aspects of European market access: structuring the technic...
Beyond User-Friendly: Mastering IEC 62366-1 for Safer MedTech and Streamlining Global Market Access with Pure Global
08 Nov 2025
Contributed by Lukas
This episode of MedTech Global Insights demystifies the critical IEC 62366-1 standard for usability engineering. We move beyond theory to explore how ...
Navigating the Maze of IEC 62304: A Pure Global Masterclass on Medical Device Software Lifecycle and Global Compliance
07 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we demystify IEC 62304, the international standard for medical device software lifecycle processes. We bre...
From Hazard to Market Approval: Pure Global Decodes the Practical Application of ISO 14971 for Medical Devices
06 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we break down the practical application of ISO 14971:2019, the essential standard for medical device risk ...
From 21 CFR Part 820 to the QMSR: Pure Global's Deep Dive into the FDA's New Quality System for MedTech Innovators
05 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the monumental shift in the U.S. FDA's approach to quality systems for medical devices. We brea...
Mastering the MedTech Clinical Evaluation Report (CER): A Deep Dive with Pure Global on MEDDEV 2.7/1 rev 4 Compliance and Avoiding Common Pitfalls
04 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we demystify one of the most critical documents for European market access: the Clinical Evaluation Report...
The Ultimate Guide to EU MDR GSPR Compliance: How Pure Global Helps You Avoid Critical Notified Body Findings
03 Nov 2025
Contributed by Lukas
This episode of MedTech Global Insights provides a deep dive into the General Safety and Performance Requirements (GSPR) of the EU MDR 2017/745, Annex...
MDSAP Explained: A Pure Global Guide to Participating Countries for MedTech & IVD Market Access
02 Nov 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the Medical Device Single Audit Program (MDSAP), a revolutionary framework allowing MedTech and...
Unlocking US Market Access: A Pure Global Masterclass on Navigating the 510(k) Submission for AI-Powered Medical Devices (SaMD)
01 Nov 2025
Contributed by Lukas
As MedTech companies increasingly integrate artificial intelligence into Software as a Medical Device (SaMD), navigating the regulatory landscape beco...
Unlocking Global MedTech Markets: A Deep Dive into IEC 81001-5-1 Cybersecurity with Pure Global
31 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the new cornerstone of medical device security, the IEC 81001-5-1 standard. As healthcare techn...
Cracking the Code: How Pure Global Helps SaMD Startups Navigate ISO 13485 Compliance
30 Oct 2025
Contributed by Lukas
SaMD developers operate in a fast-paced, agile world, but the medical device industry is governed by the structured ISO 13485 standard. This episode d...
Unlocking MedTech Innovation: A Deep Dive into the FDA's AI Change Control Policy with Pure Global's Expertise
29 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we dissect the FDA's groundbreaking final guidance on Predetermined Change Control Plans (PCCPs) for AI/ML...
Cracking the Code: A Pure Global Deep Dive into Clinical Evaluation Requirements for SaMD under the EU MDR
28 Oct 2025
Contributed by Lukas
This episode of MedTech Global Insights delves into the rigorous clinical evaluation requirements for Software as a Medical Device (SaMD) under the Eu...
Cracking the Code: A Pure Global Guide to Securing a CE Mark for AI Medical Devices Under the EU MDR
27 Oct 2025
Contributed by Lukas
Getting a CE Mark for a traditional medical device is challenging enough, but the complexity multiplies when Artificial Intelligence is involved. This...
The Pure Global MedTech Playbook: Unlocking FDA Approval for Your AI-Powered Medical Device with a Predetermined Change Control Plan
26 Oct 2025
Contributed by Lukas
The rise of AI is revolutionizing medical technology, but it presents a unique challenge for regulators. How does the FDA approve a device that is des...
Unlocking Global MedTech Markets with Pure Global: A Deep Dive into FDA vs. EU AI/ML Device Regulations and the AI Act
25 Oct 2025
Contributed by Lukas
The global landscape for AI-enabled medical devices is rapidly evolving, with the two largest markets, the United States and the European Union, chart...
Navigating SaMD Risk: A Pure Global Guide to the IMDRF Framework for MedTech Innovators
24 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we demystify the International Medical Device Regulators Forum (IMDRF) framework for Software as a Medical...
Beyond the Database: Why RegDesk Alternatives Are Key for MedTech and How Pure Global's Integrated Strategy Redefines Global Market Access
23 Oct 2025
Contributed by Lukas
Many MedTech and IVD companies rely on regulatory intelligence platforms like RegDesk for global expansion, only to discover that data alone doesn't g...
Beyond Parexel: How Pure Global's AI-Powered Strategy is Revolutionizing MedTech Global Market Access
22 Oct 2025
Contributed by Lukas
Expanding into international markets is a critical growth driver for MedTech and IVD companies, but the path is often blocked by the high costs, slow ...
Beyond the Behemoth: A MedTech Insider's Guide to Smarter Global Market Access with Pure Global as Your ICON plc Alternative
21 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we challenge the conventional wisdom of partnering with massive, one-size-fits-all CROs. While industry gi...
Rethinking MedTech Regulatory Strategy: Why Companies are Seeking Pharmalex Alternatives and Finding Success with Pure Global
20 Oct 2025
Contributed by Lukas
In the complex world of MedTech and IVD devices, selecting a regulatory partner is one of the most critical decisions for global growth. While large, ...
Beyond Freyr Solutions: How Pure Global's AI-Driven, Single-Process Approach is Redefining MedTech & IVD Global Market Access.
19 Oct 2025
Contributed by Lukas
The global MedTech regulatory landscape is notoriously complex. While established firms like Freyr Solutions have been a traditional choice, the indus...
Beyond Traditional MedTech Consulting: Why Companies Exploring Qserve Group Alternatives Choose Pure Global for AI-Powered Global Market Access
18 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we challenge the traditional, fragmented approach to regulatory consulting that often leaves MedTech and I...
Beyond MDSAP: Pure Global's Playbook for Smarter, Faster MedTech Global Market Access
17 Oct 2025
Contributed by Lukas
This episode of MedTech Global Insights challenges the one-size-fits-all approach to global regulatory compliance. We dive into the Medical Device Sin...
MedTech Global Expansion: Why Companies are Seeking Obelis Group Alternatives and Choosing a Strategic Partner like Pure Global for Market Access.
16 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the critical role of the European Authorized Representative (EAR) and why the traditional, pass...
Stuck with Traditional FDA Consultants? How Pure Global is Redefining MedTech Market Access Beyond Registrar Corp Alternatives
15 Oct 2025
Contributed by Lukas
In the world of MedTech, getting your device approved in one market is a milestone. But what happens when you aim for global scale? Many companies rel...
Beyond Emergo by UL: How Pure Global's AI-Powered, Single-Process Approach is Revolutionizing MedTech Market Access
14 Oct 2025
Contributed by Lukas
In a MedTech consulting landscape dominated by large, traditional players like Emergo by UL, many companies are seeking more agile, efficient, and tec...
Navigating ANVISA: How Pure Global Provides Best-in-Class Medical Device Registration Support for Success in Brazil
13 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we explore the immense opportunities and critical challenges of entering Brazil's medical device market. W...
Unlock Singapore's MedTech Market: Your Expert Guide to HSA Medical Device Registration with Pure Global
12 Oct 2025
Contributed by Lukas
This episode of MedTech Global Insights delves into the strategic importance and regulatory complexities of the Singaporean medical device market. We ...
Unlocking the Brazilian Market: A Pure Global Masterclass on ANVISA and INMETRO Approval for MedTech Innovators
11 Oct 2025
Contributed by Lukas
Brazil's MedTech market offers immense growth opportunities, but entry is guarded by the complex dual-gatekeeper system of ANVISA and INMETRO. This ep...
The Insider's Guide to HSA GDPMDS Compliance: How Pure Global Streamlines Singapore Market Access for MedTech Innovators
10 Oct 2025
Contributed by Lukas
In this episode of MedTech Global Insights, we dissect a crucial, yet often overlooked, aspect of entering one of Asia's premier MedTech hubs: Singapo...
Navigating ANVISA: Why Pure Global is the Best Regulatory Affairs Consultant for Medical Device Success in Brazil
09 Oct 2025
Contributed by Lukas
This episode of MedTech Global Insights delves into the complexities of entering Brazil's lucrative medical device market. We uncover the critical reg...